Loading clinical trials...
Loading clinical trials...
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ossium Health, Inc.
NCT06645132 · Blood Cancer, Bone Marrow Transplant (BMT)
NCT01685372 · Solid Organ Transplant Recipient (Liver, Kidney, Heart), Rheumatologic Disorder, and more
University of Alabama, Birmingham
Birmingham, Alabama
Henry Ford Health
Detroit, Michigan
The Ohio State University Medical Center
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions